Buxtamine is primarily used in organic synthesis as a chiral amine reagent, particularly in asymmetric catalysis and the preparation of enantiomerically enriched compounds. It serves as a valuable building block in pharmaceutical research, where its stereochemical properties enable the development of bioactive molecules with high selectivity. It is also employed in the synthesis of ligands for transition metal catalysts, enhancing reaction efficiency and stereoselectivity in key transformations such as hydrogenations and carbon-carbon bond formations. Due to its structural features, Buxtamine finds application in the design of novel catalysts for industrial and academic research settings.